Gene · 57721
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
741 to 760 of 1,078
Download this page as JSON| Grant | Title | METTL14 papers | Newest fiscal year |
|---|---|---|---|
| R01CA179120 | miRNAs:Safe and effective therapeutic adjuvants for treating drug resistant TNBC | 2 | 2019 |
| R01DK102792 | The role of mutant splicing factor SRSF2 in Myelodysplasia | 2 | 2019 |
| R01DK107615 | The molecular mechanism of clonal dominance in 5q(del) MDS | 2 | 2019 |
| R01HL131444 | The role of EVI1-induced DNA hypermethylation in Leukemogenesis | 2 | 2019 |
| R21AI140152 | Macrophage m6A mRNA Methylation in Sepsis | 2 | 2019 |
| R21CA226959 | Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein | 2 | 2019 |
| S10OD026929 | Illumina NovaSeq 6000 Sequencing System | 2 | 2019 |
| S10OD027000 | Acquisition of a High Precision Micro Diffractometer to Support NIH funded Research at SER-CAT | 2 | 2019 |
| T32GM007287 | Pre-Doctoral Training in Biological Sciences | 2 | 2019 |
| F30CA203101 | Targeting TCA cycle in Brain Tumor Initiating Cells | 1 | 2019 |
| K02AA018755 | Genes, Environments & Interventions: Understanding and Addressing Alcohol Misuse | 1 | 2019 |
| K08HL128822 | Long Non-coding RNAs in Cardiometabolic Disease | 1 | 2019 |
| K08HL128867 | Regulatory T cell Uhrf1 and DNA methylation in repair of acute lung injury | 1 | 2019 |
| P01AG043376 | Administrative Supplement to: Cell Autonomous and Non-Autonomous Mechanisms of Aging | 1 | 2019 |
| P01HL028481 | Molecular Genetic Approaches in Atherosclerosis Research | 1 | 2019 |
| P50AG005138 | Alzheimer's Disease Research Center | 1 | 2019 |
| P50AG016573 | The Alzheimer's Disease Research Center at the University of California, Irvine | 1 | 2019 |
| R00CA194192 | Linking Oncogenic Signaling to Tumor Metabolism | 1 | 2019 |
| R00CA197498 | Epigenetic mechanisms for oncogene silencing in MLL-rearranged leukemia | 1 | 2019 |
| R00CA197762 | Investigating the role of the small GTPase RIT1 in lung adenocarcinoma | 1 | 2019 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/grants?page=38